NIA Small Business Funding Opportunities

Potential applicants are strongly encouraged to read the NIH-NIA SBIR-STTR information and guidance on the NIH SBIR-STTR website.

All potential applicants are strongly encouraged to contact NIA's SBIR-STTR Program Coordinator to determine if their potential SBIR-STTR research and development would be appropriate for NIA.

NIH SBIR-STTR Funding Opportunity Announcements:

• 2018 NIH SBIR Omnibus Solicitation
• 2018 NIH STTR Omnibus Solicitation
• 2018 NIA SBIR-STTR Research Topics (PDF, 1.4M)
• 2018 NIH SBIR-STTR Omnibus SBA-Approved-Waiver Research Topics (PDF, 554K)

NIA SBIR-STTR FOAs targeting Alzheimer's disease (AD) and AD-related dementias (ADRD) and Translational Research:

1. Alzheimer's Disease (AD) and AD-related dementias (ADRD):
   • Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44);
   • Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42);
   • Tools for Clinical Care and Management of Alzheimer's Disease (AD) and its Commorbidities (R43/R44);
   • Tools for Clinical Care and Management of Alzheimer's Disease (AD) and Its Commorbidities (R41/R42);
   • Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44);
   • Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42)
   • Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer's Disease (AD/ADRD) (SBIR R43/R44 Clinical Trial Not Allowed);
   • Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer's Disease (AD/ADRD) (STTR R41/R42) Clinical Trials Not Allowed);
   • Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (SBIR R43/R44 Clinical Trial Not Allowed);
   • Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (STTR R41/R42 Clinical Trial Not Allowed).
   • Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 Clinical Trial Optional)
   • Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 Clinical Trial Optional)
2. Translational Research on Aging:
   • T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44);
   • T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44).